Dr. Giriprasad Venugopal | Genetics | Best Researcher Award

Believers Church Medical College and Hospital, Kerala- India

Author Profile

• Orcid Profile
• Google Scholar Profile

Early Academic Pursuits

Dr. Giriprasad’s fascination with life sciences took root during his undergraduate studies in Biochemistry at the University of Madras (2004–2007). This foundational period ignited a curiosity about human biology at the molecular level. His decision to pursue a Master of Science in Biochemistry (2009–2011), also from the University of Madras, signaled a deeper commitment to the field. Here, he gained exposure to advanced laboratory techniques, biochemical pathways, and emerging disease mechanisms.

His academic pursuits culminated in a PhD in Biochemistry from SRM Medical College and Hospital (SRM Institute of Science and Technology), where he worked under the Department of Medical Gastroenterology. His dissertation, titled “Serological Prevalence of Celiac Disease (CeD) and HLA-DQA1/B1 Genotypes in the General Population”, became a cornerstone study contributing to the epidemiological understanding of celiac disease in India. This research combined clinical biochemistry with molecular genetics, setting the stage for his future research path.

---

Professional Endeavors

Following his doctoral studies, Dr. Giriprasad began working as a Research Scientist at the Central Advanced Research Laboratory of Believers Church Medical College Hospital. In this role, he has been involved in cutting-edge translational research, contributing to diagnostic advancements and biomarker discovery for gastrointestinal and systemic diseases.

His professional work bridges the gap between clinical medicine and bench-side research. He collaborates with physicians, laboratory scientists, and geneticists to develop evidence-based solutions for better patient care. His responsibilities include molecular diagnostics, serological analysis, HLA genotyping, and supervising ongoing research studies. This integrated approach supports both individualized patient diagnosis and large-scale population health strategies.

---

Contributions and Research Focus

Dr. Giriprasad’s research is defined by its clinical relevance and molecular depth. His PhD dissertation explored the seroprevalence of celiac disease (CeD) and the association of HLA-DQA1/B1 genotypes, a combination that provides both diagnostic and genetic insight. This study is one of the first of its kind in India to address the genetic predisposition to CeD in the general population, offering crucial data for gastroenterologists and policy-makers.

Additionally, he has contributed to laboratory assay development and the refinement of HLA typing protocols, enhancing the precision and efficiency of diagnostic workflows. His work supports the early detection of autoimmune diseases, particularly in underdiagnosed and underserved populations.

Dr. Giriprasad’s expertise in biomolecular techniques, including PCR, ELISA, and genotyping, has significantly strengthened the research capacity of the institution. His commitment to evidence-based practice ensures that research findings are not just academic but impactful in clinical settings.

---

Accolades and Recognition

Over the years, Dr. Giriprasad has been acknowledged for his meticulous research and scholarly contributions. His PhD work, backed by clinical collaboration, has received recognition in academic forums and has informed diagnostic standards for CeD across various labs in India.

His role at a prominent hospital laboratory further amplifies his reputation as a dependable and skilled research scientist. He is regularly invited to contribute to scientific discussions, participate in multi-center studies, and co-author research papers in reputed biomedical journals.

---

Impact and Influence

Dr. Giriprasad’s research holds particular importance in the context of public health in India, where autoimmune and gastrointestinal disorders are often underdiagnosed or misdiagnosed. By establishing standardized protocols for serological and genetic testing, he has enhanced diagnostic clarity and provided avenues for early intervention.

His efforts contribute directly to precision medicine, enabling physicians to tailor treatments based on genetic and serological profiles. Moreover, his work on HLA genotyping has implications for organ transplantation, disease risk assessment, and population genetics—broadening the scope of his influence in biomedical research.

---

Legacy and Future Contributions

Dr. V. Giriprasad’s legacy is being shaped through a career of meaningful research, mentorship, and clinical collaboration. He stands as a role model for young biochemists and research students, often guiding junior colleagues in laboratory techniques, research design, and critical analysis.

Looking ahead, Dr. Giriprasad is expected to lead multi-disciplinary projects focused on autoimmune diagnostics, genetic screening, and biomarker validation. With evolving technologies and the rise of personalized medicine , his work will continue to gain importance in both national and global health contexts.

In the years to come, his ambition is likely to include international collaborations, patent-worthy innovations, and the expansion of biochemical diagnostics in India’s tier-2 and tier-3 healthcare centers. This vision aligns with the nation’s goals of universal health coverage and accessible medical research.